Sound Pharmaceuticals’ NIH Grant for a novel oral COVID-19 treatment increases to $4.2M

SEATTLE, May 11, 2022 /PRNewswire/ — Sound Pharmaceuticals, Inc. (SPI) is pleased to announce that is has received a $1.1M supplement to its $3.1M National Center for Advancing Translational Sciences (NCATS) Award, bringing the total NIH funding to $4.2M. SPI is developing ebselen…

Click here to view original post